Wigan, United Kingdom

Gillian S Ashcroft

This inventor holds 1 USPTO granted patent. Top assignee: Renovo Limited. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gillian S Ashcroft. Retrieved from https://idiyas.com/inventor/gillian-s-ashcroft

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gillian S Ashcroft: Innovator in Wound Treatment

Introduction

Gillian S Ashcroft is a notable inventor based in Wigan, GB. She has made significant contributions to the field of medical treatments, particularly in the area of wound healing and fibrotic disorders. Her innovative approach utilizes sex steroids function modulators to enhance recovery processes.

Latest Patents

Gillian holds 1 patent for her work titled "Use of sex steroids function modulators to treat wounds and fibrotic disorders." This patent focuses on the application of compounds that influence the sex hormone system for treating wounds and fibrotic conditions. The preferred compounds for these treatments are steroid hormones, especially oestrogens.

Career Highlights

Gillian is currently associated with Renovo Limited, where she continues to advance her research and development efforts. Her work has garnered attention for its potential to improve healing outcomes in patients suffering from various conditions.

Collaborations

Gillian collaborates with Mark W J Ferguson, contributing to the innovative environment at Renovo Limited. Their combined expertise enhances the research and development initiatives within the company.

Conclusion

Gillian S Ashcroft's contributions to the field of wound treatment through her innovative patent demonstrate her commitment to advancing medical science. Her work has the potential to significantly impact patient care and recovery processes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…